Skip to content

Inspection Record

Implantica CE Reflux Limited — FDA 483 Findings

US FDAInspected 2025-10-24Published 2026-10-27 4 findingsOther quality systemProcess validation

Inspectors John Sciacchitano · Kathryn Suttling · Lakecha N. LewisThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The organizational structure has not been adequately established and maintained to ensure that devices are manufactured in accordance with 21 CFR Part 820.

2Other quality system

Procedures to ensure that sampling methods are adequate for their intended use have not been adequately established.

4Other quality system

Procedures for corrective and preventive action have not been adequately established.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-27. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Implantica CE Reflux Limited company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.